Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 4,440 | 13,132 | 4,417 | 4,579 | 7,887 |
| Operating Income | -4,440 | -13,132 | -4,417 | -4,579 | -7,887 |
| Other Income | 79 | 74 | 93 | 133 | 161 |
| Pre-tax Income | -4,361 | -13,058 | -4,324 | -4,446 | -7,726 |
| Net Income Continuous | -4,361 | -13,058 | -4,324 | -4,446 | -7,726 |
| Net Income | $-4,361 | $-13,058 | $-4,324 | $-4,446 | $-7,726 |
| EPS Basic Total Ops | -0.45 | -1.93 | -1.55 | 6.03 | -6.81 |
| EPS Basic Continuous Ops | -0.45 | -1.93 | -1.55 | 6.03 | -6.81 |
| EPS Diluted Total Ops | -0.45 | -1.93 | -1.55 | 6.03 | -6.81 |
| EPS Diluted Continuous Ops | -0.45 | -1.93 | -1.55 | 6.03 | -6.81 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -1.93 | -1.55 | N/A | -6.81 |
| EBITDA(a) | $-4,412 | $-13,105 | $-4,391 | $-4,552 | $-6,328 |